维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="Ao ZF"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Combination of tetrandrine as a poten- tial-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia 显示文摘	Xu WL Shen HL Ao ZF	2006	Leuk Res2006，30，4：	1
	2	Combination of tetrandrine as a potential reversing agent with daunorubicin, etoposide and eytarabine for the treatment of refractory and relapsed acute myelogenous leukemia显示文摘	Xu WL Shen HL Ao ZF	2006	Leukemia Research2006，30，4：	1
	3	Combination of tetrandrine as a potential reversing agent with daunorubicin,etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia显示文摘	Xu WL Shen HL Ao ZF	2006	Leuk Res2006，30，4：	1
	4	ATF3 activates Stat3 phosphorylation through inhibition of p53 expression in skin cancer cells显示文摘	Hao ZF Ao JH Zhang J	2013	Asian Pac J Cancer Prev2013，14，：	1
	5	Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelagenous leukemia显示文摘	Xu WL Shen HL Ao ZF	2006	Leukemia research2006，30，4：	1
	6	Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia显示文摘	Xu WL Shen HL Ao ZF	2006	Leuk Res2006，30，4：	1
	7	Environmental investigations and molecular typing of Aspergillusin a Chinese hospital显示文摘	Ao JH Hao ZF Zhu H	2014	Mycopathologia2014，177，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费